Clinical Trials · NCT02970591

A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome

Phase
N/A
Recruitment status
Completed
Sponsor
Sahlgrenska University Hospital
Enrollment
300
Start date
Jan 2017
Locations
1 site, Sweden
Primary endpoint
The proportion (%) of patients who respond to treatment
View Linaclotide compound reference